Literature DB >> 23179135

Women with congenital heart disease: long-term outcomes after pregnancy.

A Wacker-Gussmann1, M Thriemer, M Yigitbasi, F Berger, N Nagdyman.   

Abstract

BACKGROUND: Pregnancy in women with congenital cardiac disease is more frequent due to an increased lifespan and improved health situations. However, the long-term outcomes in these women are not known.
METHODS: We analysed 267 consecutive pregnant women with congenital heart defects who were seen at the German Heart Centre Berlin. This retrospective study included analysis of long-term follow-up data after pregnancy and standard maternal cardiac, obstetric and neonatal outcomes. The long-term data (n = 103) were acquired with a self-assessment questionnaire from each patient. The main primary outcomes of the study included functional class, health, work capability and physical activity.
RESULTS: The median age of the patients at delivery was 27 years (range 17-43 years). The median follow-up of all patients was 11 years (range 1-49 years). Twenty-four percent exhibited complex cardiac defects. Primary long-term outcomes included good health in 61 % of the patients. Approximately 68 % worked, and 76 % engaged in physical activity. Thirty-three percent of the women who answered the questionnaire demonstrated a decrease in functional class during pregnancy, but more than two-thirds of these patients subsequently improved. Secondary short-term outcomes included a 4 % miscarriage rate and a 4 % induced abortion rate. The maternal cardiac data revealed that 30 % of the patients lost at least one functional class during pregnancy. Onset arrhythmias were observed in 12 % of the patients. The most prevalent neonatal complication was premature birth, which was present in 12 % of the neonates.
CONCLUSION: Two-thirds of the patients tolerated pregnancy without cardiovascular complications. Most patients displayed good long-term health, work capability and physical activity outcomes. Further prospective controlled studies are necessary to confirm these results and safely advise pregnant women.

Entities:  

Mesh:

Year:  2012        PMID: 23179135     DOI: 10.1007/s00392-012-0522-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  23 in total

1.  Daily physical activity in adults with congenital heart disease is positively correlated with exercise capacity but not with quality of life.

Authors:  Jan Müller; John Hess; Alfred Hager
Journal:  Clin Res Cardiol       Date:  2011-09-21       Impact factor: 5.460

2.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

3.  Effect of maternal heart disease on fetal growth.

Authors:  Emily Gelson; Ruth Curry; Michael A Gatzoulis; Lorna Swan; Martin Lupton; Philip Steer; Mark Johnson
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

4.  Outcome of operated and unoperated adults with congenital cardiac disease lost to follow-up for more than five years.

Authors:  Annette Wacker; Harald Kaemmerer; Regina Hollweck; Michael Hauser; Marc Andre Deutsch; Silke Brodherr-Heberlein; Andreas Eicken; John Hess
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

5.  Right ventricular function in grown-up patients after correction of congenital right heart disease.

Authors:  Julia Lemmer; Grit Heise; Axel Rentzsch; Petra Boettler; Titus Kuehne; Karl Otto Dubowy; Brigitte Peters; Bjoern Lemmer; Alfred Hager; Brigitte Stiller
Journal:  Clin Res Cardiol       Date:  2010-10-28       Impact factor: 5.460

6.  Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease.

Authors:  Samuel C Siu; Jack M Colman; Sheryll Sorensen; Jeffrey F Smallhorn; Dan Farine; Kofi S Amankwah; John C Spears; Mathew Sermer
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

7.  ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

Authors:  Vera Regitz-Zagrosek; Carina Blomstrom Lundqvist; Claudio Borghi; Renata Cifkova; Rafael Ferreira; Jean-Michel Foidart; J Simon R Gibbs; Christa Gohlke-Baerwolf; Bulent Gorenek; Bernard Iung; Mike Kirby; Angela H E M Maas; Joao Morais; Petros Nihoyannopoulos; Petronella G Pieper; Patrizia Presbitero; Jolien W Roos-Hesselink; Maria Schaufelberger; Ute Seeland; Lucia Torracca
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

8.  Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects.

Authors:  Gerda Schwedler; Angelika Lindinger; Peter E Lange; Ulrich Sax; Julianna Olchvary; Brigitte Peters; Ulrike Bauer; Hans-Werner Hense
Journal:  Clin Res Cardiol       Date:  2011-09-10       Impact factor: 5.460

Review 9.  Outcome of pregnancy in women with congenital heart disease: a literature review.

Authors:  Willem Drenthen; Petronella G Pieper; Jolien W Roos-Hesselink; Willem A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Sing C Yap; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Journal:  J Am Coll Cardiol       Date:  2007-06-04       Impact factor: 24.094

10.  Pregnancy in women with pulmonary hypertension.

Authors:  P G Pieper; E S Hoendermis
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380

View more
  5 in total

1.  Transcatheter creation of a de novo communication across an extracardiac Fontan conduit for catheter ablation of a "left-sided" accessory pathway.

Authors:  Gunter Kerst; Dietmar Schranz; Kerstin Buttgereit; Maria B Gonzalez Y Gonzalez; Volkan Tuzcu
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460

2.  Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.

Authors:  M Hoeltzenbein; E Beck; K Meixner; C Schaefer; R Kreutz
Journal:  Clin Res Cardiol       Date:  2015-07-21       Impact factor: 5.460

3.  Proposed method for evaluation and categorization of functional capacity of children, adolescents, and adults with cardiac diseases to bring them in existing social justice system by creating the cardiac disability criteria.

Authors:  Smita Mishra; Rajesh Sharma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-24

4.  [Adults with congenital heart disease: treatment and medical problems].

Authors:  A A Schmaltz; U M M Bauer
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

5.  Long-Term Cardiovascular Health After Pregnancy in Danish Women With Congenital Heart Disease. A Register-Based Cohort Study Between 1993 and 2016.

Authors:  Stine Kloster; Janne S Tolstrup; Dorte Guldbrand Nielsen; Lars Søndergaard; Søren Paaske Johnsen; Annette Kjær Ersbøll
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.